Application Nr Approved Date Route Status External Links
ANDA090778 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duloxetine Delayed-Release Capsules Are Indicated For The Treatment Of: • Major Depressive Disorder [ See Clinical Studies (14.1 )] • Generalized Anxiety Disorder [ See Clinical Studies (14.2)] • Diabetic Peripheral Neuropathy [ See Clinical Studies (14.3)] • Fibromyalgia [ See Clinical Studies (14.4)] • Chronic Musculoskeletal Pain [ See Clinical Studies (14.5)] Duloxetine Delayed-Release Capsules Are A Serotonin And Norepinephrine Reuptake Inhibitor (Snri) Indicated For: • Major Depressive Disorder (Mdd) ( 1 ) • Generalized Anxiety Disorder (Gad) ( 1 ) • Diabetic Peripheral Neuropathic Pain (Dpnp) ( 1 ) • Fibromyalgia (Fm) (1) • Chronic Musculoskeletal Pain ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Duloxetine Hydrochloride DULOXETINE HYDROCHLORIDE ZINC1536779

Comments